Rtw Investments, LP Pulmonx Corp Transaction History

Rtw Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.92 - $17.35 $914,367 - $3.22 Million	-185,847 Reduced 40.33%	275,000 $2.32 Million
Q3 2022 Nov 14, 2022	SELL	$15.35 - $23.99 $3.54 Million - $5.53 Million	-230,408 Reduced 33.33%	460,847 $7.68 Million
Q2 2022 Aug 15, 2022	SELL	$14.0 - $27.95 $1.5 Million - $2.99 Million	-107,000 Reduced 13.4%	691,255 $10.2 Million
Q1 2022 May 16, 2022	SELL	$21.13 - $35.65 $7.74 Million - $13.1 Million	-366,345 Reduced 31.46%	798,255 $19.8 Million
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $1.26 Million - $1.56 Million	35,000 Added 3.1%	1,164,600 $41.9 Million
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $44.4 Million - $78 Million	1,129,600 New	1,129,600 $74.8 Million

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.